Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $03 | $04 | $05 | $06 | $07 | $08 | $08 |
| Operating income | $222.7K5 | -$88.4K6 | -$126.2K7 | -$65.0K8 | -$73.9K8 | ||
| Net income | -$220.0K3 | -$195.6K4 | $308.7K5 | -$88.4K6 | -$126.2K7 | -$255.0K8 | -$41.8K8 |
| Earnings per share | $0.008 | $0.008 | |||||
| Earnings per share (diluted) | $0.008 | $0.008 | |||||
| Shares (weighted, basic) | 77.4M shares8 | ||||||
| Shares (weighted, diluted) | 77.4M shares8 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $1.3K4 | $1.1K5 | $605 | $5.4K6 | $4207 | $11.7K8 | $15.6K8 |
| Receivables | $08 | ||||||
| Current assets | $1.3K3 | $1.1K4 | $605 | $11.6K6 | $241.5K7 | $26.7K8 | $15.6K8 |
| Total assets | $246.8K3 | $227.2K4 | $605 | $11.6K6 | $241.5K7 | $26.7K8 | $15.6K8 |
| Current liabilities | $289.7K3 | $465.7K4 | $209.5K5 | $73.2K6 | $429.3K7 | $469.5K8 | $500.2K8 |
| Total liabilities | $569.3K3 | $745.3K4 | $209.5K5 | $73.2K6 | $429.3K7 | $469.5K8 | $500.2K8 |
| Retained earnings | -$845.0K8 | ||||||
| Shareholders’ equity | -$322.5K4 | -$518.1K5 | -$209.4K6 | -$61.6K7 | -$187.7K8 | -$442.8K8 | -$484.6K8 |
| Shares outstanding | 32.4M shares3 | 32.4M shares4 | 32.4M shares5 | 77.4M shares6 | 77.4M shares7 | 77.4M shares8 | 77.4M shares8 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
What it owns
What Bio-En Holdings Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Leadership
Who has led Bio-En Holdings Corp., and when. Pick a name to see everywhere that person has worked.
President
- PresidentElchanan Grossbaum Apr 29, 2013 to Apr 29, 201312
Board members and other officers (3)
- SecretaryEliyahu Prager Apr 29, 2013 to Apr 29, 201313
- Board memberElchanan Grossbaum Apr 29, 2013 to Apr 29, 201312
- Board memberEliyahu Prager Apr 29, 2013 to Apr 29, 201313
Former names
- Olivia Inc.Feb 13, 2013 to Feb 19, 20142
Filings
7 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 2 other. The latest 7:
- Mar 30, 2023NT 10-K FORM 12B-25 EDGAR
- Nov 14, 202210-Q EDGAR
- Aug 29, 202210-Q EDGAR
- Aug 15, 2022NT 10-Q EDGAR
- May 16, 202210-Q EDGAR
- Mar 31, 202210-K EDGAR
- Nov 15, 202110-Q EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Bio-En Holdings Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBio-En Holdings Corp.1
- CIK0001568139
- Employer ID (EIN)99-03691161
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Industry code (SIC)2050 Bakery Products1
- Business address56 Main Street, Monsey, NY 109541
- Phone84536471511
- Shares outstanding77,350,003 as of Sep 30, 202211
- Public float$0 as of Dec 31, 20218
- On EDGAR sinceFeb 13, 20131
- Filings78 in all: 10-Q (30), 8-K (11), 10-K (9), NT 10-Q (5), UPLOAD (5), NT 10-K (4), CORRESP (3), S-1/A (3)1
All 13 form types
10-Q/A (2), 3 (2), 8-K/A (2), EFFECT (1), S-1 (1)
- Latest filingsAnnual report (10-K) Mar 31, 2022
Quarterly report (10-Q) Nov 14, 2022
Latest 8-K (8-K) May 12, 2020
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARElchanan Grossbaum, President
- 13SEC EDGAREliyahu Prager, Secretary